The Anticancer Fund supports and develops clinical trials, evaluating interventions with potential clinical relevance, but little commercial interest. Drug repurposing is one such area, a drug development strategy based on the reuse of existing licensed drugs for new indications.

The Fund also uses the knowledge and expertise in their team to support patients with the My Cancer Navigator service, providing personalized, evidence-based information, explained in laymen’s terms.

Speakers: 

• Dr. Guy Buyens, Medical Director
• Dr. Gabry Kuijten, Coordinating Physician, My Cancer Navigator